Literature DB >> 7501817

Radionecrosis of the mandibula: a retrospective analysis of the incidence and risk factors.

C Glanzmann1, K W Grätz.   

Abstract

We analysed the incidence of a mandibular osteonecrosis (ON) in 189 patients irradiated for a cancer of the oral cavity, or of the oropharynx or epipharynx, with a total target dose of at least 60 Gy between 1980 and January 1994. Target doses per fraction were between 2.0 and 1.2 Gy, number of sessions per week was between 5 and 10, and total target doses were between 60 and 78.2 Gy. No instance of ON has been observed after target doses between 60 and 65 Gy. Cumulative incidence of an ON needing a mandibular resection was: 24.8% in patients treated with a mandibular dose per fraction between 2.00 and 2.22 Gy and a total mandibular dose between 66.00 and 79.70 Gy; 19.6% in patients treated with a mandibular dose per fraction between 1.80 and 1.90 Gy and a total mandibular dose between 69.00 and 75.60 Gy, 2.2% in patients treated with two fractions of 1.20 Gy per day for 5 days in the week with or without simultaneous application of cis-platinum and a total mandibular dose between 75.20 and 82.00 Gy. Dose per fraction, association of the tumour with bone, and the volume of the horizontal ramus of the mandibula irradiated with a high dose were observed to be significant risk factors.

Entities:  

Mesh:

Year:  1995        PMID: 7501817     DOI: 10.1016/0167-8140(95)01583-3

Source DB:  PubMed          Journal:  Radiother Oncol        ISSN: 0167-8140            Impact factor:   6.280


  25 in total

1.  Surgical Management of Skull Base Osteoradionecrosis in the Cancer Population - Treatment Outcomes and Predictors of Recurrence: A Case Series.

Authors:  Ahmed Habib; Matthew M Hanasono; Franco DeMonte; Ali Haider; Jonathan D Breshears; Marc-Elie Nader; Paul W Gidley; Shirley Y Su; Ehab Y Hanna; Shaan M Raza
Journal:  Oper Neurosurg (Hagerstown)       Date:  2020-09-15       Impact factor: 2.703

2.  The influence of dental treatment on the development of osteoradionecrosis after radiotherapy by modern irradiation techniques.

Authors:  Ramona Schweyen; Andreas Stang; Andreas Wienke; Alexander Eckert; Thomas Kuhnt; Jeremias Hey
Journal:  Clin Oral Investig       Date:  2017-01-13       Impact factor: 3.573

3.  Increased numbers of osteoclasts expressing cysteine proteinase cathepsin K in patients with infected osteoradionecrosis and bisphosphonate-associated osteonecrosis--a paradoxical observation?

Authors:  Torsten Hansen; C James Kirkpatrick; Christian Walter; Martin Kunkel
Journal:  Virchows Arch       Date:  2006-09-07       Impact factor: 4.064

4.  Intensity-modulated proton therapy and osteoradionecrosis in oropharyngeal cancer.

Authors:  Wencheng Zhang; Xiaodong Zhang; Pei Yang; Pierre Blanchard; Adam S Garden; Brandon Gunn; C David Fuller; Mark Chambers; Katherine A Hutcheson; Rong Ye; Stephen Y Lai; Mohamed Abdallah Sherif Radwan; X Ron Zhu; Steven J Frank
Journal:  Radiother Oncol       Date:  2017-05-23       Impact factor: 6.280

5.  The prevalence and risk factors associated with osteoradionecrosis of the jaw in oral and oropharyngeal cancer patients treated with intensity-modulated radiation therapy (IMRT): The Memorial Sloan Kettering Cancer Center experience.

Authors:  Adepitan A Owosho; C Jillian Tsai; Ryan S Lee; Haley Freymiller; Arvin Kadempour; Spyridon Varthis; Adi Z Sax; Evan B Rosen; SaeHee K Yom; Joseph Randazzo; Esther Drill; Elyn Riedel; Snehal Patel; Nancy Y Lee; Joseph M Huryn; Cherry L Estilo
Journal:  Oral Oncol       Date:  2016-12-03       Impact factor: 5.337

6.  Photodynamic therapy with meta-tetrahydroxyphenylchlorin (Foscan) in the management of squamous cell carcinoma of the head and neck: experience with 35 patients.

Authors:  Kai Johannes Lorenz; Heinz Maier
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-03-17       Impact factor: 2.503

7.  Preoperative concurrent chemotherapy with S-1 and radiotherapy for locally advanced squamous cell carcinoma of the oral cavity: phase I trial.

Authors:  Hiroyuki Harada; Ken Omura
Journal:  J Exp Clin Cancer Res       Date:  2010-04-20

Review 8.  Imaging of Radiation- and Medication-Related Osteonecrosis.

Authors:  Sanjay M Mallya; Sotirios Tetradis
Journal:  Radiol Clin North Am       Date:  2017-10-10       Impact factor: 2.303

9.  [Squamous cell carcinoma of the head and neck. Photodynamic therapy with Foscan].

Authors:  K J Lorenz; H Maier
Journal:  HNO       Date:  2008-04       Impact factor: 1.284

10.  A national survey of consultants, specialists and specialist registrars in restorative dentistry for the assessment and treatment planning of oral cancer patients.

Authors:  K Dewan; R D Kelly; P Bardsley
Journal:  Br Dent J       Date:  2014-06       Impact factor: 1.626

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.